2-Aminothiadiazole inhibitors of AKT1 as potential cancer therapeutics
- 1 March 2010
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (5), 1652-1656
- https://doi.org/10.1016/j.bmcl.2010.01.046
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Identification of 4-(4-Aminopiperidin-1-yl)-7H-pyrrolo[2,3-d]pyrimidines as Selective Inhibitors of Protein Kinase B through Fragment ElaborationJournal of Medicinal Chemistry, 2008
- CDK Inhibitors: Cell Cycle Regulators and BeyondDevelopmental Cell, 2008
- Chapter 23 Small Molecule Inhibitors of AKT/PKB Kinase as a Strategy for Treating CancerAnnual Reports in Medicinal Chemistry, 2007
- Recent progress in the discovery of Akt inhibitors as anticancer agentsExpert Opinion on Therapeutic Patents, 2007
- A Structural Comparison of Inhibitor Binding to PKB, PKA and PKA-PKB ChimeraJournal of Molecular Biology, 2007
- Improving Docking Accuracy through Molecular Mechanics Generalized Born Optimization and ScoringJournal of Chemical Theory and Computation, 2007
- Targeting the PI3K-Akt pathway in human cancer: Rationale and promiseCancer Cell, 2003
- Mutants of Protein Kinase A that Mimic the ATP-binding Site of Protein Kinase B (AKT)Journal of Molecular Biology, 2003
- Identification of a Proline-rich Akt Substrate as a 14-3-3 Binding PartnerPublished by Elsevier BV ,2003
- Synthesis of isoquinolines from indenesThe Journal of Organic Chemistry, 1980